BNC-210
id:
bnc-210-193-8654866
title:
BNC-210
text:
BNC210 is an anxiolytic drug that acts via negative allosteric modulation of the α7-nicotinic acetylcholine receptor, by Bionomics Limited. It is currently being investigated for the treatment of post traumatic stress disorder. The drug has demonstrated clinically significant anxiety reduction in both animal models and in Phase I trials. It appears to be devoid of significant sedation or memory-impairing side effects, as well as lacking addictive potential in rat discriminatory models. Phase I t
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/BNC-210
date created:
date modified:
2024-04-03T00:59:56Z
main entity:
{"identifier":"Q4836115","url":"https://www.wikidata.org/entity/Q4836115"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/6/6e/IW-2143_molecular_structure.png","width":1172,"height":1063}
fields total:
13
integrity:
15